Renaissance Capital logo

Alpha Tau Medical (Healthcare Capital Corp.) Priced, Nasdaq: DRTS

Blank check company targeting the healthcare industry (completed 3/7/2022).

Industry: SPAC

First Day Return: +2.6%

Industry: SPAC

We are a newly organized blank check company. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an initial business combination target in any stage of its corporate evolution or in any industry or sector, we currently intend to concentrate our efforts in identifying businesses across the healthcare industry, with a focus on digital and telehealth, life sciences, innovative medical devices, and healthcare technology. Our business strategy is to identify and complete our initial business combination utilizing the extensive experience of our management team and advisors, leveraging their collective knowledge and extensive relationships in the global healthcare industry. Our team understands the various significant challenges faced by the industry and the related opportunities for emerging enterprises that deliver solutions. Our target selection process will leverage our team’s skills in sourcing opportunities, evaluating problems and raising capital for healthcare enterprises.
more less
IPO Data
IPO File Date 12/21/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 24.0
Deal Size ($mm) $240
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 01/14/2021
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $240
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Wilmington, DE, United States
Founded 2020
Employees at IPO 2

Alpha Tau Medical (Healthcare Capital Corp.) (DRTS) Performance